New Brunswick, NJ, United States of America

Brendan Mack


Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2019

where 'Filed Patents' based on already Granted Patents

1 patent (USPTO):

Title: Brendan Mack - Innovator in Hepatitis C Treatment

Introduction

Brendan Mack is a notable inventor based in New Brunswick, NJ (US). He has made significant contributions to the field of medicine, particularly in the development of treatments for viral infections. His work focuses on innovative methods that can potentially improve patient outcomes.

Latest Patents

Brendan Mack holds 1 patent related to Hepatitis C virus inhibitors. His patent details methods for making asunaprevir, which is a useful treatment for Hepatitis C virus (HCV) infection, along with its intermediates. This invention represents a crucial advancement in the fight against Hepatitis C.

Career Highlights

Brendan Mack is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His role involves research and development aimed at creating effective therapies for various diseases. His expertise and dedication have positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Brendan has collaborated with notable colleagues, including Scott A. Savage and Nathan R. Domagalski. These partnerships have fostered a collaborative environment that enhances innovation and accelerates the development of new treatments.

Conclusion

Brendan Mack's contributions to the field of Hepatitis C treatment exemplify the impact of innovative thinking in medicine. His work not only advances scientific knowledge but also holds the potential to improve the lives of many patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…